| 000 | 00768 a2200229 4500 | ||
|---|---|---|---|
| 005 | 20250514045634.0 | ||
| 264 | 0 | _c20030703 | |
| 008 | 200307s 0 0 eng d | ||
| 022 | _a0340-6245 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAledort, Louis M | |
| 245 | 0 | 0 |
_aCan costs of hemophilia products be curtailed? Not as we do business today! _h[electronic resource] |
| 260 |
_bThrombosis and haemostasis _cOct 2002 |
||
| 300 |
_a541 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aBlood Coagulation Factors _xeconomics |
| 650 | 0 | 4 | _aCost Control |
| 650 | 0 | 4 | _aDisease Transmission, Infectious |
| 650 | 0 | 4 |
_aHemophilia A _xeconomics |
| 650 | 0 | 4 | _aHumans |
| 773 | 0 |
_tThrombosis and haemostasis _gvol. 88 _gno. 4 _gp. 541 |
|
| 999 |
_c12174109 _d12174109 |
||